Medical history was made at Emek Medical Center in Afula this week when semi-liquid live human bone tissue grown in a lab from a 40-year-old patient’s own fat cells was transplanted into the patient’s arm by injection.
The patient had suffered significant bone loss in his arm as the result of a car accident and previously underwent several unsuccessful surgeries.
The procedure was part of an early-stage clinical trial of a revolutionary tissue-engineering technology developed by Bonus BioGroup of Haifa. A hospital spokeswoman told ISRAEL21c that it is too early to report results in this specific case.
In December 2016, Bonus BioGroup announced successful results of an early-stage clinical trial on 11 patients in which bone tissue grown from a small sample of each patient’s own fat cells was injected into their jaws to repair bone loss. Over a few months it hardened and merged with the existing bone to complete the jaw, according to the company.—More…
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.Commenting Policy
Pursuant to Title 17 U.S.C. 107, other copyrighted work is provided for educational purposes, research, critical comment, or debate without profit or payment. If you wish to use copyrighted material from this site for your own purposes beyond the 'fair use' exception, you must obtain permission from the copyright owner. Views are those of authors and not necessarily those of Canada Free Press. Content is Copyright 1997-2017 the individual authors. Site Copyright 1997-2017 Canada Free Press.Com Privacy Statement